MedTrace Logo

The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome

NCT04542538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9905

Last updated 2021-04-28

No results posted yet for this study

Summary

The Corona virus disease 2019 (COVID-19) pandemic is currently involving all parts of the world. Several risk factors for critical illness and death from the disease have been proposed. However, it is still unclear if the observed associations between different comorbidities and chronic medications and severe COVID-19 disease and mortality is different from associations between the same factors and other severe diseases requiring intensive care unit (ICU) -care. This is important since some of the observed risk factors are very common in the aged who, by age alone, are more prone to a more severe course of any disease. By combining several registries, this study will compare, on several comorbidities such as hypertension and diabetes , the first 2000 cases of COVID-19 patients receiving critical care in Sweden to a Swedish sepsis-cohort and a Swedish adult respiratory distress syndrome (ARDS) -cohort.

Conditions

  • Sepsis
  • Corona Virus Infection
  • ARDS, Human

Interventions

OTHER

No intervention, observational study

Sponsors & Collaborators

  • Center for Clinical Research Dalarna, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Miklos Lipcsey, PhD · Uppsala University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2020-06-04
Completion
2021-01-11

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542538 on ClinicalTrials.gov